Company: SNSE
Filing Date: 2025-04-11
Form Type: DEF 14A
Source: 0000950170-25-053033
Chunk: 22

Company: Sensei Biotherapeutics, Inc.
Filing Date: 2025-04-11
Form: DEF 14A
Chunk 22
---
 recommending candidates to serve on our Board of Directors;                                                                              |
| • |     | determining the minimum qualifications for service on our Board of Directors;                                                                                                   |
| • |     | evaluating director performance on the Board of Directors and applicable committees of the board and determining whether continued service on our board is appropriate;         |
| • |     | evaluating nominations by stockholders of candidates for election to our Board of Directors;                                                                                    |
| • |     | considering and assessing the independence of members of our Board of Directors;                                                                                                |
| • |     | evaluating our set of corporate governance policies and principles and recommending to our Board of Directors any changes to such policies and principles;                      |
| • |     | reviewing and making recommendations to the Board of Directors with respect to management succession planning;                                                                  |
| • |     | considering questions of possible conflicts of interest of directors as such questions arise; and                                                                               |
| • |     | reviewing and evaluating on an annual basis the performance of the Nominating and Corporate Governance Committee and the Nominating and Corporate Governance Committee charter. |

The Nominating and Corporate Governance Committee believes that candidates for director should have certain minimum qualifications, including the ability to read and understand basic financial statements, being over 21 years of age and having the highest personal integrity and ethics. The Nominating and Corporate Governance Committee also intends to consider such factors as possessing relevant expertise upon which to be able to offer advice and guidance to management, having sufficient time to devote to the affairs of the Company, demonstrated excellence in his or her field, having the ability to exercise sound business judgment and having the commitment to rigorously represent the long-term interests of the Company’s stockholders. However, the Nominating and Corporate Governance Committee retains the right to modify these qualifications from time to time. Candidates for director nominees are reviewed in the context of the current composition of the Board, the operating requirements of the Company and the long-term interests of stockholders. In conducting this assessment, the Nominating and Corporate Governance Committee typically considers a range of age, skills and such other factors as it deems appropriate, given the current needs of the Board and the Company, to maintain a balance of knowledge, experience and capability. Diversity is one of a number of factors, however, that the committee takes into account in identifying nominees, and the Nominating and Corporate Governance Committee believes that it is essential that the board members represent diverse viewpoints. In the case of incumbent directors whose terms of office are set to expire, the Nominating and Corporate